Lifeboat Foundation: Safeguarding Humanity
Toggle light / dark theme

Blog

Category: biotech/medical – Page 43

Specialized transporters relay lipids to cellular targets

In addition to providing energy, lipids are also essential building blocks of our cell membranes. However, despite their importance, they remain poorly understood. A research team has revealed for the first time the secrets of their transport within cells. Each lipid uses a limited number of proteins to move from its place of production to its place of action. The team has also compiled an inventory of the proteins involved in the transport of hundreds of lipids.

These findings, published in the journal Nature, provide a better picture of the functioning of our cells, as well as of many genetic and metabolic disorders, such as diabetes and Alzheimer’s disease.

Biologists brought together more than a hundred transfer proteins with hundreds of different lipids. The aim was to obtain the most comprehensive list possible of the ‘pairs’ formed between each protein and the lipids it can carry.

To do this, two experimental methods were combined. The first, carried out in a test tube, provides a highly controlled environment, while the second, which more closely corresponds to the inside of a cell, allows researchers to verify how these bonds are formed under near-real conditions. This is a world first on such a scale and at such a level of complexity. “The ‘‘couples’’ identified show that transfer proteins are not “buses” capable of transporting most lipids, but private chauffeurs with specific characteristics,” explains the senior author.

Scientists have been able to determine, using advanced mathematical models, how three transfer proteins recognise, among all lipids, those that they actually transport. ScienceMission sciencenewshighlights.

Low-input proteomics identifies vWF as a negative regulator of Tet2 mutant hematopoietic stem cell expansion

Jassinskaja, Bode et al. provide a multi-omics characterization of Tet2-mutated cells, including global proteomics revealing novel roles for extracellular matrix (ECM) molecules in selectively modifying self-renewal divisions. These findings point more broadly to physical and mechanical mediators of self-renewal, implicating integrins and cytokine signaling as extracellular drivers of clonal expansion.

T-DXd/Pertuzumab Earns Type II Application Validation in EU for HER2+ mBC

The EMA has validated a Type II Variation marketing authorization application for T-DXd plus pertuzumab in first-line unresectable or metastatic HER2-positive breast cancer.

Click for more ➡️

The marketing authorization was based on results from the DESTINY-Breast09 trial assessing T-DXd/pertuzumab in first-line HER2+ metastatic breast cancer.

Virus-Specific T Cells and Response to Checkpoint Inhibitors in PML

Patients with detectable virus-specific T cells before checkpoint inhibitor therapy in PML demonstrated better survival rates and functional recovery than those without.

Question Are pretreatment JC virus-and/or BK virus-specific T cells in the blood associated with the efficacy of immune checkpoint inhibitors (ICIs) in progressive multifocal leukoencephalopathy (PML)?

Findings In this cohort study of 111 patients with PML treated with ICIs, those with detectable virus-specific T cells (n = 21) had significantly higher response rates and longer survival than both T cell–negative patients (n = 22) and those with unknown status (n = 68).

Patients with Carpal Tunnel Syndrome show increased reliance on vision in reaching-to-grasp: a study of in-flight grasp kinematics in compressive nerve injury

Reach for this new ArticleinPress!(Michela Paroli et al. Bangor University)

The fluid efficiency of everyday hand actions such as reaching-to-grasp is underpinned by finely calibrated, anticipatory, in-flight control of the hand. Peripheral nerve dysfunction could affect this control. We used Carpal Tunnel Syndrome (CTS), a compressive neuropathy of the median nerve, as a model of nerve dysfunction. Whether CTS affects in-flight aspects of reaching-to-grasp is unknown. We compared kinematics of movements in CTS and healthy controls, using motion capture. We varied object properties to determine whether anticipatory signatures of reaching-to-grasp are preserved in CTS. We also examined the effect of removing visual feedback at movement onset. This manipulation forces greater reliance on non-visual control signals, which should highlight impairments due to CTS, while indexing how much movements rely on vision.

Shingles Vaccine Linked to Slower Biological Aging, Study Finds

Vaccines may do far more than prevent infections.

The way that some inoculations train your immune system could also reduce the risk of cancer, stroke, or heart attacks, and possibly guard against dementia.

New evidence shows that the shingles vaccine is linked to slower aging, with benefits that can last for several years after vaccination.

Key protein can restore aging neural stem cells’ ability to regenerate

Researchers at the Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine), have found that a key protein can help to regenerate neural stem cells, which may improve aging-associated decline in neuronal production of an aging brain.

Published in Science Advances, the study identified a transcription factor in the brain, cyclin D-binding myb-like transcription factor 1 (DMTF1), as a critical driver of neural stem cell function during the aging process. Transcription factors are proteins that regulate genes to ensure that they are expressed correctly in the intended cells.

The study, led by Assistant Professor Ong Sek Tong Derrick and first author Dr. Liang Yajing, both from the Department of Physiology and the Healthy Longevity Translational Research Program at NUS Medicine, sought to identify biological factors that influence the degeneration of neural stem cell function often associated with aging, and guide the development of therapeutic approaches to mitigate the adverse effects of neurological aging.

Peripheral neuropathy protection by mitochondrial transfer from glia to neurons

For millions living with nerve pain, even a light touch can feel unbearable. Scientists have long suspected that damaged nerve cells falter because their energy factories known as mitochondria don’t function properly.

Now research published in Nature suggests a way forward: supplying healthy mitochondria to struggling nerve cells.

Using human tissue and mouse models, researchers found that replenishing mitochondria significantly reduced pain tied to diabetic neuropathy and chemotherapy-induced nerve damage. In some cases, the relief lasted up to 48 hours.

Instead of masking symptoms, the approach could fix what the team sees as the root problem — restoring the energy flow that keeps nerve cells healthy and resilient.

“By giving damaged nerves fresh mitochondria — or helping them make more of their own — we can reduce inflammation and support healing,” said the study’s senior author. “This approach has the potential to ease pain in a completely new way.

The work highlights a previously undocumented role for satellite glial cells, which appear to deliver mitochondria to sensory neurons through tiny channels called tunnelling nanotubes.

When this mitochondrial handoff is disrupted, nerve fibers begin to degenerate — triggering pain, tingling and numbness, often in the hands and feet, the distal ends of the nerve fibers.

Continue reading “Peripheral neuropathy protection by mitochondrial transfer from glia to neurons” | >

Plant Discovery Could Transform How Medicines Are Made

Plants produce protective chemicals called alkaloids as part of their natural defenses. People have used these compounds for a long time, including in pain relief medicines, treatments for various diseases, and familiar household products such as caffeine and nicotine.

Scientists want to learn exactly how plants build alkaloids. With that knowledge, they hope to create new and improved medicine-related chemicals faster, at lower cost, and with less harm to the environment.

In a study at the University of York, researchers examined a plant called Flueggea suffruticosa, which makes an especially strong alkaloid known as securinine. As they traced how securinine is produced, the team found a surprise: a key step depends on a gene that resembles bacterial genes more than typical plant genes.

/* */